CellSeed's Regenerative medicine technology
-
CellSeed continue to focus our efforts on commercializing cell sheet regenerative medicine to bring these products to market.
Latest News
- IR Summary of Non-Consolidated Financial Results for the Year Ended December 31, 2023 (J-GAAP)
- IR Announcement Regarding Termination of Collaboration Agreement with MetaTech (AP) Inc. in Taiwan
- IR Summary of Non-Consolidated Financial Results for the Nine Months Ended September 30, 2023 (J-GAAP)
- Others Bridge Report the first half of the fiscal year ending December 2023
- IR Fiscal 2023 First-Half Earnings Results Presentation